|
2009
|
Invention
|
Compounds having crth2 antagonist activity.
Compounds of general formula (I)
Compounds of gene... |
|
|
Invention
|
Compounds having crth2 antagonist activity. Compounds of general formula (I) W is chloro or fluor... |
|
|
Invention
|
Compounds having crth2 antagonist activity. Compounds of general formula (I): wherein W is chloro... |
|
|
Invention
|
Compounds having crth2 antagonist activity. Compounds of general formula (I) wherein W is chloro ... |
|
2008
|
Invention
|
Use of crth2 antagonist compounds. The invention relates to compounds of general formula (I) wher... |
|
|
Invention
|
Use of crth2 antagonist compounds. The invention relates to compounds of general formula (I): whe... |
|
2007
|
Invention
|
Compounds having crth2 antagonist activity. Compounds of general formula (I) wherein R is phenyl ... |
|
|
Invention
|
Salts with crth2 antagonist activity.
The potassium, sodium, ammonium, lysine, diethylamine, tro... |
|
|
Invention
|
Salts with crth2 antagonist activity. The potassium, sodium, ammonium, lysine, diethylamine, trom... |
|
2006
|
Invention
|
1-acetic acid-indole derivatives with pgd2 antagonist activity. Compounds of general formula: (I)... |
|
|
Invention
|
Microcrystalline (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid.
The invention... |
|
|
Invention
|
Microcrystalline ( 5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid. The invention... |
|
2005
|
Invention
|
Pyrrolopyridine derivatives and use thereof for treating diseases mediated by prostaglandin d2 (p... |
|
2004
|
Invention
|
Method for detection of mip-4 and ccrl2 binding and activity modulating agents. A method of detec... |
|
|
Invention
|
Agents modulating the activity of ccrl2 and methods of using the same. A method of detecting an a... |
|
|
Invention
|
Use of crth2 antagonist compounds in therapy. Compounds of general formula (I) wherein R1, R2 , R... |
|
|
Invention
|
Compounds having crth2 antagonist activity.
Compounds of general formula (I):
wherein
... |
|
|
Invention
|
Compounds having crth2 antagonist activity. Compounds of general formula (I) and their pharmaceut... |
|
|
Invention
|
Compounds with pgd2 antagonist activity. Compounds of general formula (I); wherein R1, R2, R3 and... |
|
|
Invention
|
Method of determining susceptibility to inflammatory bowel disease. The present invention relates... |
|
|
Invention
|
Method of diagnosins a genetic susceptibility for bone damage. The present invention relates to t... |
|
|
Invention
|
Receptor proteins. A method of determining whether an individual is predisposed to inflammatory b... |
|
2003
|
Invention
|
Genetic susceptibility. The present invention relates to the identification of a novel nucleotide... |
|
|
Invention
|
Genetic predisposition analysis and treatment. The present invention relates to methods of determ... |
|
2002
|
Invention
|
Diagnosis of inflammatory bowel disease. A novel gene associated with inflammatory bowel disease,... |
|
|
Invention
|
Single nucelotide polymorphisms of the seek1 gene associated withpsoriasis. The present invention... |
|
2001
|
Invention
|
Corneodesmosin based test and model for inflammatory disease. The present invention relates to a ... |
